Market Pulse LIVECAST Terminal Brief Politics Macro Calendar

More

Stocks About Why SquawkNews Newsroom Schedule Prediction Markets Disclosure Wire Crypto Search

Market Pulse LIVECAST

Menu

Home Market Pulse LIVECAST Terminal Brief Politics Macro Calendar Stocks About Why SquawkNews Newsroom Schedule Prediction Markets Disclosure Wire Crypto Search

Live News EQUITY L impact Jul 13, 2026, 11:01 AM UTC

Bristol Myers says FDA accepts NDA for mezigdomide

Bristol Myers Squibb...

SquawkNews Newsroom

Bristol Myers Squibb...

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

BMY

Related stories

Morning Juice - US Session Prep (13th July) Morning Juice - US Session Prep (13th July) L impact | EQUITY | Jul 13, 2026, 12:10 PM UTC CEL-SCI to launch FDA registration-enabling Phase 3 Confirmatory study CEL-SCI Corporation... L impact | EQUITY | Jul 13, 2026, 12:10 PM UTC LogProstyle reports FY26 EPS Y32.16 vs. Y34.76 last year Reports revenue $140M vs.... L impact | EQUITY | Jul 13, 2026, 12:08 PM UTC Maersk Says WAF6 Service Will Now Transit Via Red Sea Maersk Says WAF6 Service Will Now Transit Via Red Sea L impact | EQUITY | Jul 13, 2026, 12:06 PM UTC Maersk: The WAF6 service will now transit via the Red Sea. Maersk: The WAF6 service will now transit via the Red Sea. L impact | EQUITY | Jul 13, 2026, 12:06 PM UTC Intel: Intel invests €5b to expand manufacturing in Europe $INTC Intel: Intel invests €5b to expand manufacturing in Europe $INTC L impact | EQUITY | Jul 13, 2026, 12:04 PM UTC

SQUAWK/NEWS

Real-time financial news agency. Market-moving headlines, macro, politics, filings and audio squawk built for traders.

Product

LiveCast
Terminal
Brief
Macro
Calendar
Search

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact

© 2026 SquawkNews robots / sitemap SquawkNews publishes factual market information and context. It is not investment advice and does not provide trade recommendations.